Pfizer revenue misses as breast cancer drug sales disappoint

(Reuters) - Pfizer Inc's quarterly revenue missed analysts' estimates on Tuesday, hurt by lower-than-expected sales of blockbuster breast cancer drug Ibrance and arthritis drug Xeljanz.

from Reuters: Top News http://uk.reuters.com/article/uk-pfizer-results/pfizer-revenue-misses-as-breast-cancer-drug-sales-disappoint-idUKKBN1I23EB?feedType=RSS&feedName=topNews